Metabolism of Anethole Dithiolethione by Rat and Human Liver Microsomes: Formation of Various Products Deriving from Its O-Demethylation and S-Oxidation. Involvement of Cytochromes P450 and Flavin Monooxygenases in These Pathways

被引:10
作者
Dulac, Martin [1 ]
Sassi, Amor [1 ]
Nagarathinan, Citra [1 ]
Christen, Marie-Odile [2 ]
Dansette, Patrick M. [1 ]
Mansuy, Daniel [1 ]
Boucher, Jean-Luc [1 ]
机构
[1] Univ Paris 05, Lab Chim & Biochim Pharmacol & Toxicol, CNRS, UMR 8601, 45 Rue St Peres, F-75006 Paris, France
[2] Marie Odile Christen Behav, Paris, France
关键词
CHEMOPREVENTION; IDENTIFICATION; DITHIOLTHIONE; QUANTITATION; TRITHIONE; BINDING; AGENT;
D O I
10.1124/dmd.118.082545
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A study of the metabolism of anethole dithiolethione (ADT, 5-(p-methoxyphenyl)-3H-1,2-dithiole-3-thione) by rat and human liver microsomes showed the formation of the corresponding S-oxide and the S-oxide of desmethyl-ADT (dmADT, 5-(p-hydroxyphenyl)3H-1,2-dithiole-3-thione), and of p-methoxy-acetophenone (pMA) and p-hydroxy-acetophenone (pHA), in addition to the previously described metabolites, dmADT, anethole dithiolone (ADO, 5-(p-methoxyphenyl)-3H-1,2-dithiole-3-one) and its demethylated derivative dmADO [5-(p-hydroxyphenyl)-3H-1,2-dithiole-3-one]. The microsomal metabolism of ADO under identical conditions led to dmADO and to pMA and pHA. The metabolites of ADT derive from two competing oxidative pathways: an O-demethylation catalyzed by cytochromes P450 and an S-oxidation mainly catalyzed by flavin-dependent monooxygenases (FMO) and, to a minor extent, by CYP enzymes. The most active human CYP enzymes for ADT demethylation appeared to be CYP1A1, 1A2, 1B1, 2C9, 2C19, and 2E1. ADT S-oxidation is catalyzed by FMO 1 and 3, and to a minor extent by CYP enzymes such as CYP3A4.
引用
收藏
页码:1390 / 1395
页数:6
相关论文
共 35 条
[1]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[2]   Therapeutic potential of dithiolethiones for hepatic diseases [J].
Brooks, Samuel Carroll, III ;
Brooks, Janie Sue ;
Lee, Woo Hyung ;
Lee, Myung Gull ;
Kim, Sang Geon .
PHARMACOLOGY & THERAPEUTICS, 2009, 124 (01) :31-43
[3]   Human flavin-containing monooxygenases [J].
Cashman, JR ;
Zhang, J .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2006, 46 :65-100
[4]   STRUCTURAL AND CATALYTIC PROPERTIES OF THE MAMMALIAN FLAVIN-CONTAINING MONOOXYGENASE [J].
CASHMAN, JR .
CHEMICAL RESEARCH IN TOXICOLOGY, 1995, 8 (02) :165-181
[5]  
[陈民辉 Chen Minhui], 2013, [中国新药杂志, Chinese Journal New Drugs], V22, P2328
[6]   Design, synthesis, and pharmacological evaluation of the aqueous prodrugs of desmethyl anethole trithione with hepatoprotective activity [J].
Chen, Pei ;
Luo, Yu ;
Hai, Li ;
Qian, Shan ;
Wu, Yong .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (07) :3005-3010
[7]  
CHRISTEN MO, 1995, METHOD ENZYMOL, V252, P316
[8]  
Correia M.A., 2005, CYTOCHROME P450 STRU, V3rd, P247, DOI DOI 10.1007/0-387-27447-2_7
[9]  
Couto M, 2015, FUTURE MED CHEM, V7, P857, DOI [10.4155/FMC.15.32, 10.4155/fmc.15.32]
[10]   Improvement in solubility and dissolution rate of 1,2-dithiole-3-thiones upon complexation with β-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives [J].
Dollo, G ;
Le Corre, P ;
Chollet, M ;
Chevanne, F ;
Bertault, M ;
Burgot, JL ;
Le Verge, R .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (09) :889-895